BioNTech, Fosun Pharmaceutical launch another COVID-19 vaccine trial

"The study is designed to support the regulatory approval process for the Chinese market and intends to confirm that the safety and immunogenicity profile observed in participants from the German and US trials is comparable to that of Chinese participants," BioNTech said in a statement.

from Moneycontrol Business News https://ift.tt/31p3nGF